{
    "organizations": [],
    "uuid": "94a04bafcf4c32470cb34f178b4ebb5ca9e602ba",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amgen-receives-positive-opinion-ex/brief-amgen-receives-positive-opinion-expanding-use-of-xgeva-idUSFWN1QD15Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Receives Positive Opinion Expanding Use Of Xgeva (Denosumab)",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Amgen Inc:\n* AMGEN RECEIVES POSITIVE OPINION EXPANDING USE OF XGEVAÂ® (DENOSUMAB) TO COVER PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA IN EUROPE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T21:50:00.000+02:00",
    "crawled": "2018-02-24T13:32:44.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "receives",
        "positive",
        "opinion",
        "expanding",
        "use",
        "denosumab",
        "cover",
        "prevention",
        "event",
        "patient",
        "multiple",
        "myeloma",
        "europe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}